Sanofi (company)
Sanofi is one of the world's leading pharmaceutical corporations.[1][2]
Sanofi works in more than a hundred countries. The company is headquartered in Paris.[3]
Overview
The company started its work on August 20, 2004 by merging Sanofi-Synthelabo and Aventis. Since then, Sanofi-Synthelabo owns 95.47% of the share capital of Aventis.[4]
Structure
Sanofi is diversified company. Sanofi's subsidiaries are
- Sanofi Pasteur — production of vaccines;
- Genzyme — an innovative biotechnology company;
- Chattem — production of over-the-counter drugs;
- Merial — production of veterinary drugs;
- Zentiva — production of generics.
Sanofi also has several foundations:
Management
From October 28, 2014, the acting head of the company is Serge Weinberg.
The company's shareholders as of June 30, 2009 were:[8]
- 9.60% of shares in Total;
- 8.99% at L'Oreal;
- 1.37% of the company's employees;
- 0.76% of treasury shares;
- 79.28% in free circulation.
Activity
The main directions of the company's work now are:[9]
- Emerging markets;
- Diabetes;
- Vaccines;
- Health products;
- Innovative products;
- Animal health.
Sanofi-Pasteur's vaccine division provides vaccines against the following infectious diseases: cholera, diphtheria, meningococcal infection, pertussis, tetanus, tuberculosis etc.
In 2020, Sanofi together with GlaxoSmithKline began developing a vaccine against COVID-19.[10]
References
- ↑ "Sanofi names Viehbacher as new CEO - USATODAY.com". usatoday30.usatoday.com. Retrieved 2021-04-23.
- ↑ Annual report form 20F 2017.
- ↑ "Contact - Sanofi". www.sanofi.com (in français). Retrieved 2021-04-23.
- ↑ "Компания «sanofi-aventis» сменила название". Аптека online. Retrieved 2021-04-23.
- ↑ "Aventis Foundation: Home". www.aventis-foundation.org. Retrieved 2021-04-23.
- ↑ "Home". www.fondation-sanofi-espoir.com. Archived from the original on 2021-04-23. Retrieved 2021-04-23.
- ↑ "Patient Assistance Foundation". Archived from the original on 2011-12-11. Retrieved 2021-04-23.
- ↑ "Sanofi Shareholders". Archived from the original on 2008-11-12. Retrieved 2021-04-23.
- ↑ "Sanofi Strategy". Archived from the original on 2013-09-27. Retrieved 2021-04-23.
- ↑ (in en) Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04537208. Retrieved 2021-04-23.